ProQR Therapeutics NV (PRQR)
1.44
+0.03
(+2.13%)
USD |
NASDAQ |
Jun 11, 16:00
1.435
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Price to Book Value : 3.502 for June 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 11, 2026 | 3.502 |
| June 10, 2026 | 3.429 |
| June 09, 2026 | 3.575 |
| June 08, 2026 | 3.721 |
| June 05, 2026 | 3.648 |
| June 04, 2026 | 3.721 |
| June 03, 2026 | 3.575 |
| June 02, 2026 | 3.575 |
| June 01, 2026 | 3.454 |
| May 29, 2026 | 3.843 |
| May 28, 2026 | 3.818 |
| May 27, 2026 | 3.794 |
| May 26, 2026 | 3.818 |
| May 22, 2026 | 3.794 |
| May 21, 2026 | 3.502 |
| May 20, 2026 | 3.478 |
| May 19, 2026 | 3.478 |
| May 18, 2026 | 3.672 |
| May 15, 2026 | 3.867 |
| May 14, 2026 | 4.013 |
| May 13, 2026 | 4.135 |
| May 12, 2026 | 3.891 |
| May 11, 2026 | 3.916 |
| May 08, 2026 | 3.843 |
| May 07, 2026 | 3.843 |
| Date | Value |
|---|---|
| May 06, 2026 | 4.183 |
| May 05, 2026 | 3.964 |
| May 04, 2026 | 3.989 |
| May 01, 2026 | 3.770 |
| April 30, 2026 | 3.818 |
| April 29, 2026 | 3.746 |
| April 28, 2026 | 3.600 |
| April 27, 2026 | 3.624 |
| April 24, 2026 | 3.770 |
| April 23, 2026 | 3.964 |
| April 22, 2026 | 4.256 |
| April 21, 2026 | 4.220 |
| April 20, 2026 | 4.475 |
| April 17, 2026 | 4.84 |
| April 16, 2026 | 4.743 |
| April 15, 2026 | 4.84 |
| April 14, 2026 | 4.84 |
| April 13, 2026 | 4.378 |
| April 10, 2026 | 4.500 |
| April 09, 2026 | 4.816 |
| April 08, 2026 | 4.451 |
| April 07, 2026 | 4.135 |
| April 06, 2026 | 4.402 |
| April 02, 2026 | 4.159 |
| April 01, 2026 | 4.159 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pharming Group NV | 3.359 |
| NewAmsterdam Pharma Co. NV | 5.306 |
| Kamada Ltd. | 1.655 |
| Syndax Pharmaceuticals, Inc. | 38.10 |
| Opus Genetics, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 9.715 |
| PEG Ratio | -0.0645 |
| Price | 1.44 |
| Earnings Yield | -34.90% |
| Market Cap | 151.72M |
| PEGY Ratio | -0.0645 |